US2014220128A1PendingUtilityA1
Solid Dosage Form
Est. expiryAug 24, 2026(~0.1 yrs left)· nominal 20-yr term from priority
A61P 19/10A61K 31/663A61K 9/2077A61J 3/10A61K 9/5015A61K 9/2081A61K 9/5026A61K 9/501A61K 9/5031A61K 31/675A61K 9/2054C07F 9/3865
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof.
Claims
exact text as granted — not AI-modified1 - 42 . (canceled)
43 . A method for formulating a solid dosage form, comprising:
(i) combining particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof with a coating solution or suspension consisting essentially of a coating and a solvent, wherein the coating contains a pharmaceutically acceptable, water soluble sugar and the amount of coating is from 10% to 70% by weight of the uncoated particles; (ii) drying the solution or suspension to form coated particles of bisphosphonate; (iii) mixing the coated particles of (ii) with one or more excipients; and (iv) forming the coated particles and one or more excipients into a solid dosage form.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.